Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
Crossref DOI link: https://doi.org/10.1007/s10067-014-2857-y
Published Online: 2015-01-22
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bykerk, Vivian P.
Östör, Andrew J. K.
Alvaro-Gracia, José
Pavelka, Karel
Ivorra, José Andrés Román
Graninger, Winfried
Bensen, William
Nurmohamed, Michael T.
Krause, Andreas
Bernasconi, Corrado
Aassi, Maher
Sibilia, Jean
License valid from 2015-01-22